the-infoshop.com - The vertical markets research portal
View CartView Cart
Global Information, Inc.
US: +1-860-674-8796
EU: +32-2-535-7543
SG: +65-6223-2436
  Home | Category | Publishers | Custom Research | E-mail Alert | About Us | Contact Us | Site Map |
 

* View All Categories
View Conferences
Japanese Korean Chinese

Market Research Report

Commercial Insight: Infectious Diseases Overview

Published by Datamonitor Contact us : +1-860-674-8796
Published 2007/12 Content info 278 pages
Product code DC58750
Price From  US $ 15200 Order/Price list
US $ 15200 PDF by E-mail (Single User License)
US $ 38000 PDF by E-mail (Global License)
Delivery Time
PDF by E-Mail
Approx. 1-2 business days
Hard Copy/CD-ROM
Approx. 3-4 business days
If you need expedited delivery, please call us.
Description TOC

Abstract

Overview

Introduction

A total of 11 companies make up the top five across each of the four ID sectors, their core competencies ranging from a single disease area to generics prowess, producing a comprehensive portfolio to providing a specific offerings corresponding to highest unmet need. This report characterises the key players in each sector, and their approach to maximising their returns from a pressurised sector.

Scope

  • An inter and intra-sector overview of the four major components of the chemotherapeutic anti-infectives market in Japan, the US, and M5EU
  • Disease backgrounds for each sector, drawing attention to the key clinical issues and unmet needs that shape commercial strategies for success
  • Market size, structure, brand and company orientation by sector
  • Portfolio analysis of the leading players by sector, highlighting winning tactics and strategies in portfolio management

Report Highlights

  • 10 players in infectious disease account for two thirds of 7 major market chemotherapeutic anti-infective sales by value, but just one third by volume. However, as growth rates for the $38bn have fallen over the 2005-06 period, these companies have, collectively, been worst hit - leading to a need for strategic re-evaluations for some players.
  • This has placed an increased emphasis on high value niches of the market, and the need for effective tactics to ensure revenue loss minimisation (including, for example, OTC leveraging), line extension (reformulation and own generic production) and product succession in different measures.
  • Other approaches have included minimising exposure to an anticipated continued shrinkage in the infectious disease market through scaling back infectious disease oriented operations altogether, focusing in on either areas considered to offer highest growth, or securing an exclusive grasp of a particular niche.

Reasons to Purchase

  • Understand the clinical and commercial characteristics and priorities for the major anti-infectives markets across Japan, the US and M5EU
  • Identify the elements of strategies that have either kept players at the top of their field or failed to facilitate growth
  • Understand how these businesses and strategies relate to your interest in the market, and how to position your products and services accordingly
Related Report
Back to Top
Please inform me when related publications are released
InfoWatch

US: 1-860-674-8796 EU: 32-2-535-7543 SG: 65-6223-2436
The vertical markets research portal
© 2009, the-infoshop.com by Global Information, Inc. All rights reserved.